Tertensif Side Effects

Common Tertensif Side Effects

The most commonly reported Tertensif side effects (click to view or check a box to report):

Blood Pressure Decreased (2)
Angina Pectoris (2)
Hyponatraemia (2)
Blood Glucose Abnormal (2)
Transient Global Amnesia (2)
Renal Failure Chronic (2)
Nausea (2)
Headache (1)
Eye Swelling (1)
Gastritis (1)
Confusional State (1)
Hypokalaemia (1)
Condition Aggravated (1)
Oedema Peripheral (1)
Malaise (1)
Listless (1)
Pain In Extremity (1)
Sensation Of Heaviness (1)
Somnolence (1)
Swelling (1)

➢ More

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Tertensif Side Effects Reported to FDA

The following Tertensif reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Tertensif on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Cerebrovascular Disorder
This is a report of a 69-year-old male patient (weight: NA) from SLOVENIA, suffering from the following symptoms/conditions: NA, who was treated with Tertensif - Slow Release (dosage: 1.5 Mg, Unk, start time: Mar 16, 2010), combined with:
  • Aspirin
  • Aliskiren (150 Mg, Qd)
  • Prenessa (8 Mg, Unk)
  • Edemid (40 Mg, Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Cerebrovascular Disorder
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Tertensif - Slow Release treatment in male patients, resulting in cerebrovascular disorder side effect.

Atrial Fibrillation, Angina Pectoris
This report suggests a potential Tertensif Sr Atrial Fibrillation, Angina Pectoris side effect(s) that can have serious consequences. A male patient (weight: NA) from SWITZERLAND was diagnosed with the following symptoms/conditions: NA and used Tertensif Sr (dosage: Unk) starting Oct 14, 2010. Soon after starting Tertensif Sr the patient began experiencing various side effects, including:
  • Atrial Fibrillation
  • Angina Pectoris
Drugs used concurrently:
  • Plavix (Unk)
  • Ramipril
  • Ranibizumab (0.5 Mg, Unk)
  • Acard (Unk)
  • Simvastatin (Unk)
The patient was hospitalized. Although Tertensif Sr demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as atrial fibrillation, may still occur.

Pain In Extremity, Eye Swelling, Blood Pressure Decreased, Transient Global Amnesia, Blood Glucose Abnormal, Oedema Peripheral, Brain Oedema
This Pain In Extremity, Eye Swelling, Blood Pressure Decreased, Transient Global Amnesia, Blood Glucose Abnormal, Oedema Peripheral, Brain Oedema problem was reported by a consumer or non-health professional from POLAND. A 61-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jan 28, 2004 this consumer started treatment with Tertensif - Slow Release (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Tertensif - Slow Release, the patient experienced the following unwanted symptoms/side effects:
  • Pain In Extremity
  • Eye Swelling
  • Blood Pressure Decreased
  • Transient Global Amnesia
  • Blood Glucose Abnormal
  • Oedema Peripheral
  • Brain Oedema
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pain in extremity, may become evident only after a product is in use by the general population.

Nausea, Gastritis
This is a report of a female patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: NA and was treated with Tertensif (dosage: NA) starting Aug 23, 2010. Concurrently used drugs:
  • Aspenter
  • Digoxin
  • Madopar /00349201/
  • Amaryl
  • Nebivolol Hcl
  • Rivotril
  • Rotigotine (rotigotine) ((2 Mg Qd) ; (4 Mg Qd) ; (6 Mg Qd) ; (8 Mg Qd))
  • Rotigotine (rotigotine) ((2 Mg Qd) ; (4 Mg Qd) ; (6 Mg Qd) ; (8 Mg Qd))
Soon after that, the consumer experienced the following side effects:
  • Nausea
  • Gastritis
The patient was hospitalized. This opens a possibility that Tertensif treatment could cause the above reactions, including nausea, and some female subjects may be more susceptible.

Transient Global Amnesia, Swelling, Blood Glucose Abnormal, Blood Pressure Decreased
A 67-year-old male patient (weight: NA) from POLAND with the following symptoms/conditions: hypertension started Tertensif - Slow Release treatment (dosage: NA) on NS. Soon after starting Tertensif - Slow Release treatment, the subject experienced various side effects, including:
  • Transient Global Amnesia
  • Swelling
  • Blood Glucose Abnormal
  • Blood Pressure Decreased
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Tertensif - Slow Release.

Blood Pressure Ambulatory Increased, Listless, Malaise, Sensation Of Heaviness, Syncope
A 73-year-old male patient from CROATIA (local name: Hrvatska) (weight: NA) experienced symptoms, such as: hypertension and was treated with Tertensif - Slow Release(dosage: NA). The treatment was initiated on Feb 02, 2010. After that a consumer reported the following side effect(s):
  • Blood Pressure Ambulatory Increased
  • Listless
  • Malaise
  • Sensation Of Heaviness
  • Syncope
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Tertensif - Slow Release efficacy: NA.

Angina Pectoris, Hypokalaemia
In this report, Tertensif was administered for the following condition: hypertension.A 76-year-old female consumer from SPAIN (weight: NA) started Tertensif treatment (dosage: NA) on Mar 01, 2008.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Angina Pectoris
  • Hypokalaemia
A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Tertensif treatment could be related to the listed above side effect(s).

Confusional State, Hyponatraemia
This is a report of the following Tertensif side effect(s):
  • Confusional State
  • Hyponatraemia
A 69-year-old female patient from (weight: NA) presented with the following condition: hypertension,epilepsy and received a treatment with Tertensif (dosage: NA) starting: Jan 01, 2003.The following concurrently used drugs could have generated interactions:
  • Trileptal
The patient was hospitalized.This report suggests that a Tertensif treatment could be associated with the listed above side effect(s).

Headache, Hyponatraemia, Nausea, Somnolence
This Tertensif - Slow Release report was submitted by a 70-year-old female consumer from (weight: NA). The patient was diagnosed with: hypertension and Tertensif - Slow Release was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Headache
  • Hyponatraemia
  • Nausea
  • Somnolence
Other drugs used simultaneously:
  • Quinapril
The patient was hospitalized.Those unexpected symptoms could be linked to a Tertensif - Slow Release treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Renal Failure Chronic
This is a report of a possible correlation between Tertensif - Slow Release use and the following symptoms/side effect(s):
  • Renal Failure Chronic
which could contribute to an assessment of Tertensif - Slow Release risk profile.A 86-year-old female consumer from (weight: NA) was suffering from NA and was treated with Tertensif - Slow Release (dosage: NA) starting Nov 16, 2003.Other concurrent medications:
  • Torsemide
  • Valsartan
The patient was hospitalized.

Condition Aggravated, Renal Failure Chronic
A 86-year-old female patient from (weight: NA) presented with the following symptoms: NA and after a treatment with Tertensif - Slow Release (dosage: NA) experienced the following side effect(s):
  • Condition Aggravated
  • Renal Failure Chronic
The treatment was started on Nov 16, 2003. Tertensif - Slow Release was used in combination with the following drugs:
  • Torsemide
  • Valsartan
The patient was hospitalized.This report could alert potential Tertensif - Slow Release consumers.

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Tertensif Side Effects

    Did You Have a Tertensif Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor

    How Effective is Tertensif for You?

    Exceeded Expectations
    Somewhat Effective
    Not Effective

    Tertensif Safety Alerts, Active Ingredients, Usage Information

    More About Tertensif

    Side Effects reported to FDA: 11

    Tertensif safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 5

    Latest Tertensif clinical trials

    Tertensif Reviews

    No reviews, be a first to report a side effect via side effect reporting form